Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Rademikibart by Suzhou Connect Biopharmaceuticals for Asthma: Likelihood of Approval
Rademikibart is under clinical development by Suzhou Connect Biopharmaceuticals and currently in Phase II for Asthma. According to GlobalData, Phase...
Data Insights
Rademikibart by Suzhou Connect Biopharmaceuticals for Asthma: Likelihood of Approval
Rademikibart is under clinical development by Suzhou Connect Biopharmaceuticals and currently in Phase II for Asthma. According to GlobalData, Phase...